Ma Hui, Hu Yi, Jiang Wei-li, Wang Wei-bing, Xu Biao
Department of Epidemiology, School of Public Health, Fudan University, the Key Laboratory on Public Health Safety, Ministry of Education, Shanghai 200032, China.
Zhonghua Jie He He Hu Xi Za Zhi. 2011 Jun;34(6):447-50.
To investigate the distribution of Mycobacterium tuberculosis (MTB) Beijing genotype, which was isolated from tuberculosis (TB) patients registered in local TB dispensaries in Deqing and Guanyun county respectively within 1 year, as well as its drug-resistant phenotypic and genotypic profiles and genotyping features.
A total of 399 TB patients were enrolled from 2 counties. Of the 351 TB patients with MTB isolates available, 237 were male, and 114 were female; aged from 18 - 82 (46 ± 35) years. The proportion method and DNA sequencing were used to define the susceptibility of the isolates to 4 first line anti-TB drugs and the related mutation. Beijing genotype MTB strains were identified by Spoligotyping, while the "cluster" strains and the "unique" strains were defined by IS6110 restriction fragment length polymorphism (RFLP).
Beijing genotype MTB strains were identified in 243 of the 351 strains isolated, and the proportion of multi-drug resistance, mono-resistance to rifampin and isoniazid among Beijing genotype MTB was 18.5% (45/243), 43.2% (105/243) and 22.2% (54/243) respectively, all being significantly higher than the non-Beijing genotype MTB, 7.4% (8/108), 24.1% (26/108) and 12.0% (13/108) respectively. katG and rpoB mutations were observed more common among Beijing genotype MTB than among non-Beijing genotype MTB, 13.2% (32/243) and 4.6% (5/108) respectively, OR = 2.553, 95%CI: 1.031 - 6.324. The Beijing genotype MTB was more likely to be clustered than non-Beijing genotype MTB, 41.2% (100/243) and 11.1% (12/108) respectively, OR = 5.503, 95%CI: 2.851 - 10.622.
In eastern rural China, TB patients infected with the Beijing genotype MTB may have a higher risk to develop isoniazid-or rifampin-resistance and multi-drug resistance. The disease is more likely due to recent transmission.
调查分别从德清县和灌云县当地结核病防治机构登记的结核病患者中分离出的结核分枝杆菌(MTB)北京基因型的分布情况,以及其耐药表型、基因型特征和基因分型特点。
从2个县共纳入399例结核病患者。在351例有MTB分离株的结核病患者中,男性237例,女性114例;年龄18 - 82岁(46±35岁)。采用比例法和DNA测序确定分离株对4种一线抗结核药物的敏感性及相关突变。通过间隔寡核苷酸分型(Spoligotyping)鉴定北京基因型MTB菌株,采用插入序列6110(IS6110)限制性片段长度多态性(RFLP)定义“簇状”菌株和“独特”菌株。
在351株分离株中鉴定出243株北京基因型MTB菌株,北京基因型MTB中耐多药、对利福平单耐药和对异烟肼单耐药的比例分别为18.5%(45/243)、43.2%(105/243)和22.2%(54/243),均显著高于非北京基因型MTB,分别为7.4%(8/108)、24.1%(26/108)和12.0%(13/108)。北京基因型MTB中katG和rpoB突变的发生率高于非北京基因型MTB,分别为13.2%(32/243)和4.6%(5/108),比值比(OR)=2.553,95%置信区间(CI):1.031 - 6.324。北京基因型MTB比非北京基因型MTB更易聚类,分别为41.2%(100/243)和11.1%(12/108),OR = 5.503,95%CI:2.851 - 10.622。
在中国东部农村地区,感染北京基因型MTB的结核病患者发生异烟肼或利福平耐药及耐多药的风险可能更高。该疾病更可能是近期传播所致。